In Committee
Expedited Access to Biosimilars Act
Sponsor
Rep. Langworthy, Nicholas A. [R-NY-23]Republican · New YorkCommittee
Energy and Commerce CommitteeLast action
Referred to the House Committee on Energy and Commerce.
Jul 13, 2026
Referred to the House Committee on Energy and Commerce. · Jul 13, 2026
Introduced Jul 13, 2026
Members signed on after the sponsor
Offered against this measure
No roll calls stored
9 organizations reported lobbying on this bill, through 3 lobbying firms.
From Lobbying Disclosure Act reports that name this bill. Reports do not say how much of a quarter's spending went to any one bill, so none is attributed here.